Krystal Biotech (KRYS) Cash & Equivalents Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 62.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.36% |
| Dec 31, 2025 | 43.91% |
| Sep 30, 2025 | 4.98% |
| Jun 30, 2025 | 2.33% |
| Mar 31, 2025 | -13.99% |
| Dec 31, 2024 | -3.76% |
| Sep 30, 2024 | 0.19% |
| Jun 30, 2024 | 25.34% |
| Mar 31, 2024 | 155.08% |
| Dec 31, 2023 | 121.33% |
| Sep 30, 2023 | 100.23% |
| Jun 30, 2023 | 26.13% |
| Mar 31, 2023 | -47.74% |
| Dec 31, 2022 | -52.56% |
| Sep 30, 2022 | -34.96% |
| Jun 30, 2022 | -33.63% |
| Mar 31, 2022 | -33.04% |
| Dec 31, 2021 | 27.20% |
| Sep 30, 2021 | 1.50% |
| Mar 31, 2021 | 123.15% |
| Dec 31, 2020 | 43.07% |
| Sep 30, 2020 | 44.95% |
| Mar 31, 2020 | 83.88% |
| Dec 31, 2019 | 80.88% |
| Sep 30, 2019 | 317.44% |
| Jun 30, 2019 | 346.24% |
| Mar 31, 2019 | 107.53% |
| Dec 31, 2018 | 109.05% |
| Sep 30, 2018 | -11.23% |
| Jun 30, 2018 | 1,088.54% |
| Mar 31, 2018 | 2,355.95% |
| Dec 31, 2017 | 2,478.84% |
| Sep 30, 2017 | 13,108.54% |